Location of Repository

By what mechanism does ondansetron inhibit colonic migrating motor complexes: does it require endogenous serotonin in the gut wall?

By Nicholas John Spencer, Sarah J Nicholas, TC Sia, V Staikopoulos, Melinda Kyloh and EA Beckett

Abstract

This is the accepted version of the following article: [Spencer, N. J., Nicholas, S. J., Sia, T. C., Staikopoulos, V., Kyloh, M. and Beckett, E. A. (2013), By what mechanism does ondansetron inhibit colonic migrating motor complexes: does it require endogenous serotonin in the gut wall?. Neurogastroenterology & Motility, 25: 677–685.], which has been published in final form at [http://dx.doi.org/10.1111/nmo.12136]. In addition, authors may also transmit, print and share copies with colleagues, provided that there is no systematic distribution of the submitted version, e.g. posting on a listserve, network or automated delivery.5-HT3 antagonists, such as ondansetron (Zofran), retard colonic transit and provide effective relief of symptoms of chronic diarrhea and diarrhea-predominant irritable bowel syndrome (IBS), but the mechanism by which ondansetron retards transit is unclear. What is clear is that the frequency of colonic migrating motor complexes (CMMCs) is reduced by ondansetron, which could account for reduced transit. Our aim was to determine whether an acute depletion of 5-HT from enteric neurons would inhibit spontaneous CMMCs; and determine whether the sensitivity of ondansetron to reduce CMMC frequency would change in a 5-HT-depleted preparation

Topics: Migrating myoelectric complex, Myenteric plexus, Drug testing
Publisher: Wiley-Blackwell
Year: 2013
DOI identifier: 10.1111/nmo.12136
OAI identifier: oai:dspace.flinders.edu.au:2328/26983
Journal:

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.